The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia

BACKGROUND: Optimal anticoagulation strategy for cardiopulmonary bypass (CPB) in end-stage heart failure patients with heparin-induced thrombocytopenia (HIT) requiring left ventricular assist device (LVAD) implantation remains uncertain. Presently, there are no large-scale randomized studies compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Gernhofer, Yan K., Ross, Michael, Khoche, Swapnil, Pretorius, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904976/
https://www.ncbi.nlm.nih.gov/pubmed/29665860
http://dx.doi.org/10.1186/s13019-018-0721-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904976/
https://www.ncbi.nlm.nih.gov/pubmed/29665860
http://dx.doi.org/10.1186/s13019-018-0721-x

Ejemplares similares